COVID-19 2024–2025 vaccines are recommended for everyone aged 6 months and older, with vaccines targeting the JN.1 and KP.2 strains of SARS-CoV-2.

A single COVID-19 mRNA vaccine dose provided similar protection to that conferred by a 2-dose series among immunocompetent ...

Older adults who received the bivalent BNT162b2 vaccine were less likely to develop long COVID symptoms follow acute ...

Early antiviral therapy with obeldesivir was safe and well tolerated in patients at high risk for severe COVID-19 and ...

In patients with uncomplicated UTI, the presence of positive vs negative ESBL uropathogens differed by symptom severity, race, and age plus recurrent UTI history.

The policy of billing for secure messages changes patient expectations and can impact the patient-physician relationship.

A survey has found that, in cardiology, burnout is common among health care workers, with nurses reporting the highest rates ...

HealthDay News — The presence of persistent antigen is associated with having postacute sequelae of COVID-19 (PASC) symptoms, ...

As an outbreak of bird flu among dairy cows continues to spread in the US, 2 more cases have been reported in dairy workers, this time in CA.

There were no safety concerns identified among older adults following revaccination with the investigational respiratory syncytial virus vaccine mRNA-1345, and immune responses elicited by ...

The RSV vaccine Abrysvo was highly effective against hospital and ED encounters in a large cohort of older adults with comorbidities and immunocompromising conditions.

Lithium aspartate is not effective for neurologic post-COVID-19 condition symptoms of fatigue and cognitive dysfunction.